Amgen Technology Private Limited

Amgen Technology Private Limited - research & development in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN U62099MH2007FTC168485 Incorporated 08 March 2007 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Foreign Private Limited Company research and development
Data last updated
Revenue · FY 2025
₹166.38 Cr
▲ 601.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
19 yrs
Est. 2007
Employees · EPFO
22
Latest available

About Amgen Technology Private Limited

Data last updated: 22 December 2025

Amgen Technology Private Limited is a foreign private limited company based in Mumbai, Maharashtra, India, a subsidiary of Amgen Worldwide Holdings B V. The company specialises in research and development. Incorporated on 08 March 2007, the company has been in operation for over 19 years.

Registered with ROC Mumbai under CIN U62099MH2007FTC168485.

Capital: an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mansi Jayantilal Malkan and David Ewan Foulstone.

Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Park, Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹166.38 Cr, reflecting significant growth compared to the previous year.

The company has a workforce of approximately 22 employees as per the latest available data. It operates as a subsidiary of Amgen Worldwide Holdings B V.

The company is associated with 1 brand - Amgen.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website amgen.com.

Company Details of Amgen Technology Private Limited
CIN U62099MH2007FTC168485
Registration Number 168485
Incorporation Date 08 March 2007
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Amgen Worldwide Holdings B V
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Registered Address
    10Th Floor Nesco Tower 4 C Wing Western Express Highway Goregaon (E) Nesco I., T. Park, Mumbai, Maharashtra, India – 400063
  • Industry
    Research & Development, Research & Development
Company report
Amgen Technology Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Amgen Technology Private Limited report

Financials, compliance, directors, charges, ownership and filings for Amgen Technology Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Amgen Technology Private Limited

Amgen Technology Private Limited has one previous CIN (Corporate Identification Number): U24110MH2007FTC168485. The current CIN is U62099MH2007FTC168485, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U62099MH2007FTC168485 Current
U24110MH2007FTC168485 Previous

Associated Brands with Amgen Technology Private Limited

Amgen Technology Private Limited operates one associated brand: Amgen. These brands represent Amgen Technology Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Developer of pharmaceutical products for treating multiple diseases amgen.com

Competitors & Alternatives of Amgen Technology Private Limited

Brands and companies operating in the same space as Amgen Technology Private Limited include Merck, Roivant Sciences, AbbVie and 7 more.

Competitor Description Location Founded
Merck Merck Pharmaceutical products are manufactured and marketed worldwide. Kenilworth, United Kingdom, United Kingdom 1891
Roivant Sciences Roivant Sciences Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. New York, United States, United States 2014
AbbVie AbbVie Biopharmaceutical research and drug development are conducted globally by AbbVie. Chicago, United States, United States 2012
Lilly Lilly Traditional pharmaceutical medicines are developed for multiple health fields. United States 1876
Gilead Gilead Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others Foster City, United States, United States 1987
United Therapeutics United Therapeutics Treatments for chronic and life-threatening diseases are developed and commercialized. Silver Spring, United States, United States 1998
Roche Roche Pharmaceuticals and diagnostics kits are developed for various diseases. Basel, Switzerland, Switzerland 1896
Ascendis Pharma Ascendis Pharma Long-acting prodrug therapies are developed for endocrine and rare diseases. Hellerup, Denmark, Denmark 2007
MorphoSys MorphoSys Therapeutic antibodies for cancer and other diseases are developed. Planegg, Germany, Germany 1992
Vertex Pharmaceuticals Vertex Pharmaceuticals Developer of drugs for the treatment of multiple disorders United States 1989

Business Activity of Amgen Technology Private Limited

Amgen Technology Private Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including scientific research and development.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
M Professional, Scientific and Technical M5 Scientific research and development Locked
Premium access

Business activity turnover details for Amgen Technology Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Amgen Technology Private Limited

Amgen Technology Private Limited is audited by S R B C & CO LLP for the financial year 2022. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
S R B C & CO LLP Locked Locked Locked
Premium access

Complete auditor history for Amgen Technology Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Amgen Technology Private Limited

Amgen Technology Private Limited is currently managed by 5 directors, with 12 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Mansi Jayantilal Malkan Director 15 Sep 2017 8 Years 11 Months Current
David Ewan Foulstone Director 20 Mar 2024 2 Years 5 Months Current
Ng Lian Eric Teck Director 31 Aug 2017 8 Years 11 Months Current
Naveen Gullapalli Whole-Time Director 23 Apr 2025 1 Years 3 Months Current
Mihir Kumar Ojha Whole-Time Director 09 May 2025 1 Years 3 Months Current

Financials of Amgen Technology Private Limited FY 2024 filings available

Amgen Technology Private Limited reported revenue of ₹166.38 Cr (up 601.00% YoY) for FY 2025.

Revenue · FY 2025
₹166.38 Cr ▲ 601.00%
Premium access

Ten-year financial statements for Amgen Technology Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Amgen Technology Private Limited

Premium access

Shareholding and ownership data for Amgen Technology Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings Amgen Technology Private Limited

Amgen Technology Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Amgen Technology Private Limited

Amgen Technology Private Limited has a workforce of 22 employees as of Apr 01, 2024.

Employee count
22
Active EPFO establishments
1
Employee growth
-15.38%
Premium access

Employee and EPFO history for Amgen Technology Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Amgen Technology Private Limited

Premium access

GST registrations and filing compliance for Amgen Technology Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Amgen Technology Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Amgen Technology Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Amgen Technology Private Limited

Premium access

MSME payment history for Amgen Technology Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Amgen Technology Private Limited

Premium access

Corporate group structure for Amgen Technology Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Amgen Technology Private Limited

Premium access

MCA filings and documents for Amgen Technology Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Amgen Technology Private Limited

Directors
09 May 2025
Mihir Kumar Ojha was appointed as a Whole-time director on 09 May 2025 & has been associated with this company since 1 year 3 months.
Directors
23 Apr 2025
Naveen Gullapalli was appointed as a Whole-time director on 23 Apr 2025 & has been associated with this company since 1 year 3 months.
Activity
30 Sep 2024
Amgen Technology Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Activity
31 Mar 2024
Amgen Technology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Directors
20 Mar 2024
David Ewan Foulstone was appointed as a Director on 20 Mar 2024 & has been associated with this company since 2 years 5 months.
Directors
15 Sep 2017
Mansi Jayantilal Malkan was appointed as a Director on 15 Sep 2017 & has been associated with this company since 8 years 11 months.

Frequently Asked Questions about Amgen Technology Private Limited

Amgen Technology Private Limited is an active foreign private limited company in the research and development sector based in Mumbai, Maharashtra, India. It was incorporated on 08 March 2007 (19+ years old) and is registered under CIN U62099MH2007FTC168485. The company has 22 employees.

Amgen Technology Private Limited reported revenue of ₹166.38 Cr for FY 2025 (up 601.00% YoY).

The current directors of Amgen Technology Private Limited are:

The primary industry of Amgen Technology Private Limited is research and development. The company specifically operates in research and development. The company is currently active in this sector.

Amgen Technology Private Limited can be reached at the registered office: 10Th Floor Nesco Tower 4 C Wing Western Express Highway Goregaon E Nesco I, T. Park, Mumbai, Maharashtra, India – 400063, or through the website amgen.com.

The authorised capital is ₹5 Lakh, and the paid-up capital is ₹1 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available